Abstract
A number of studies have postulated cell surface gangliosides to be receptors for various bioactive factors such as glycoprotein hormones,1–3 interferon,4–6 and bacterial toxins,7–9 based on the interaction of gangliosides with these bioactive factors or ganglioside modification of the cellular effect of these factors. These observations, however, do not necessarily prove or support the idea that gangliosides function as receptors for these factors. In fact, in most of these cases, the receptor has been subsequently characterized as a protein, and the binding to gangliosides is generally of much lower affinity and specificity. With the exception of cholera toxin binding to the oligosaccharide moiety of GM1,10 few examples of ganglioside receptors have been demonstrated. Our recent studies on the effect of gangliosides on cell growth have suggested that gangliosides may alter the binding of polypeptide growth factors to their receptors in an indirect way.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
B. R. Mullin, P. H. Fishman, G. Lee, Sm. M. Aloj, F. D. Ledley, R. J. Winand, L. D. Kohn, and R. O. Brady, Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc. Natl. Acad. Sci. USA 73:842 (1976).
G. Lee, S. M. Aloj, R. O. Brady, and L. D. Kohn, The structure and function of glycoprotein hormone receptors: Ganglioside interactions with human chorionic gonadotropin, Biochem. Biophys. Res. Commun. 73:370 (1976).
G. Lee. S. M. Aloj, and L. D. Kohn, The structure and function of glycoprotein hormone receptors: Ganglioside interactions with luteinizing hormone, Biochem. Biophys. Res. Commun. 77:434 (1977).
F. Besancon, and H. Ankel, Binding of interferon to gangliosides, Nature (Lond.) 252:478 (1974).
V. E. Vengris, R. H. Reynolds, M. D. Hollenberg, and P. M. Pitha, Interferon action: Role of membrane gangliosides, Virology 72:486 (1976).
H. Ankel, C. Krishnamaurti, F. Besancon, S. Stefanos, and E. Falcoff, Mouse fibroblast (type I) and immune (type II) interferons: Pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells, Proc. Natl. Acad. Sci. USA 77:2528 (1974).
A. M. Haywood, Characteristics of Sendai virus receptors in a model membrane, J. Mol. Biol. 83:427 (1974).
J. Holmgren, L. Svennerholm, H. Elwing, P. Fredman, and O. Strannegard, Sendai virus receptor: Proposed recognition structure based on binding to plastic-adsorbed gangliosides, Proc. Natl. Acad. Sci. USA 77:1947 (1980).
F. D. Ledley, G. Lee, L. D. Kohn, W. H. Habig, and M. C. Hardegree, Tetanus toxin interactions with thyroid plasma membranes, J. Biol. Chem. 252:4049 (1977).
P. Cuatrecasas, Interaction of Vibrio cholerae enterotoxin with cell membranes, Biochemistry 12:3547 (1973).
S. Hakomori, Glycosphingolipids in cellular interaction, differentiation, and oncogenesis, Annu. Rev. Biochem. 50:733 (1981).
R. A. Laine, and S. Hakomori, Incorporation of exogenous glycosphingolipids in plasma membranes of cultured hamster cells and concurrent change of growth behavior, Biochem. Biophys. Res. Commun. 54:1039 (1973).
I. Icarel-Liepkalns, V. A. Liepkalns, A. J. Yates, and R. E. Stephens, Cell cycle phases of a novel human neural cell line and the effect of exogenous gangliosides, Biochem. Biophys. Res. Commun. 105:225 (1982).
T. W. Keenan, E. Scmid, W. W. Franke, and H. Wiegandt, Exogenous glycosphingolipids suppress growth rate of transformed and untransformed 3T3 cells, Exp. Cell Res. 92:259 (1975).
D. Barnes, and G. Sato, Methods for growth of cultured cells in serum-free medium, Anal. Biochem. 102:255 (1980).
T. Macaig, B. Kelley, J. Cerundolo, S. Ilsley, P. R. Kelley, J. Gaudreau, and R. Forand, Hormonal requirements of baby hamster kidney cells in culture, Cell Biol. Int. Reports 4:43 (1980).
E. Raines, and R. Ross, Platelet-derived growth factor. I. High yield purification and evidence for multiple forms, J. Biol. Chem. 257:5154 (1982).
D. F. Bowen-Pope, and R. Ross, Platelet-derived growth factor. II. Specific binding to cultured cells, J. Biol. Chem. 257:5161 (1982).
G. Scatchard, The attraction of proteins for small molecules and ions, Ann. N. Y. Acad. Sci. 51:660 (1949).
E. G. Bremer, and S. Hakomori, GM3 ganglioside induces haster fibroblast growth inhibition in chemically-defined medium: Gangliosides may regulate growth factor receptor function, Biochem. Biophys. Res. Commun. 106:711 (1982).
S. Batzri, and E. D. Korn, Single bilayer liposomes prepared without sonication, Biochim. Biophys. Acta 298:1015 (1973).
S. Kanda, K. Inone, S. Nojima, H. Utsumi, and H. Wiegandt, Incorporation of spin-labeled ganglioside analogues into cell and liposomal membranes, J. Biochem. 91:1707 (1982).
P. H. Fishman, J. Moss, and M. Vaughan, Uptake and metabolism of gangliosides in transformed mouse fibroblasts: Relationship of ganglioside structure to choleragen response, J. Biol. Chem. 251:4490 (1976).
D. M. Marcus, and L. Cass, Glycosphingolipids with Lewis blood group activity: Uptake by human erythrocytes, Science 164:553 (1969).
G. Schwarzmann, A simple and novel method for tritium labeling of gangliosides and other sphingolipids, Biochim. Biophys. Acta 529:106 (1978).
D. Gospodorowicz, Purification of a fibroblast growth factor from bovine pituitary, J. Biol. Chem. 250:2515 (1975).
S. Cohn, G. Carpenter, and L. King, Jr., Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity, J. Biol. Chem. 255:4834 (1979).
K. Glenn, D. F. Bowen-Pope, and R. Ross, Platelet-derived growth factor. III. Identification of platelet-derived growth factor receptor by affinity labeling, J. Biol. Chem. 257:5172 (1982).
F.J. Sharom, and C. W. M. Grant, A model for ganglioside behavior in cell membranes, Biochim. Biophys. Acta 507:280 (1978).
C. A. Longwood, S. Hakomori, and T. H. Ji, A glycolipid and its associated proteins: Evidence by crosslinking of human erythrocyte surface components, FEBS Lett. 112:265 (1980).
W. A. Valente, P. Vitti, Z. Yavin, E. Yavin, E. F. Grollman, R. S. Toccafondi, and L. D. Kohn, Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease, Proc. Natl. Acad. Sci. USA 79:6680 (1982).
L. S. Lee, and I. B. Weinstein, Tumor-promoting phorbol esters inhibit the binding of epidermal growth factor to cellular receptors, Science 202:313 (1978).
M. Shoyab, and G. T. Todaro, Perturbation of membrane phospholipids alters the interaction between epidermal growth factor and its membrane receptors, Arch. Biochem. Biophys. 296:222 (1981).
J. B. Baker, G. S. Barsh, D. H. Carney, and D. D. Cunningham, Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture, Proc. Natl. Acad. Sci. USA 75:1882 (1978).
E. Rozengurt, K. D. Brown, and P. Petticum, Vasopressin inhibition of epidermal growth factor binding to cultured mouse cells, J. Biol. Chem. 256:716 (1981).
C. Heldin, A. Wasteson, and B. Westemark, Interaction of platelet-derived growth factor with its fibroblast receptor: Demonstration of ligand degradation and receptor modulation, J. Biol. Chem. 257:4216 (1982).
D. F. Bowen-Pope, P. E. DiCorleto, and R. Ross, Interactions between the receptors for platelet-derived growth factors and epidermal growth factor, J. Cell Biol. 96:679 (1983).
J. Schlessinger, A. B. Schreiber, A. Levi, I. Lax, T. Libermann, and Y. Yarden, Regulation of cell proliferation by epidermal growth factor, Critical Reviews in Biochemistry 14:93 (1983).
J. Nishimura, J. S. Huang, and T. F. Duel, Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes, Proc. Natl. Acad. Sci. USA 79:4303 (1982).
J. Pouyssegur, J. C. Chambard, A. Franchi, S. Paris, and E. Van Obberghen-Schilling, Growth factor activation of an amiloride-sensitive Na+ /H+ exchange system in quiescent fibroblasts: Coupling to ribosomal protein S6 phosphorylation, Proc. Natl. Acad. Sci. USA 79:3935 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Bremer, E.G., Hakomori, Si. (1984). Gangliosides as Receptor Modulators. In: Ledeen, R.W., Yu, R.K., Rapport, M.M., Suzuki, K. (eds) Ganglioside Structure, Function, and Biomedical Potential. Advances in Experimental Medicine and Biology, vol 174. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1200-0_32
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1200-0_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1202-4
Online ISBN: 978-1-4684-1200-0
eBook Packages: Springer Book Archive